TI  - Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study
AU  - Öksüm Solak, E.
AU  - Gökçek, G.E.
AU  - Çınar, L.
AU  - Kartal, D.
AU  - Borlu, M.
SO  - Journal of Clinical Practice and Research 2021;43:267-272.
DO  - 10.14744/etd.2020.82356